Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Arm, Open-label, Phase II Study Evaluating the Efficacy and Safety of Abemaciclib in Patients With Recurrent Oligodendroglioma

NCT03969706 is registered in ClinicalTrials.gov with Stephen Bagley, MD, MSCE as lead sponsor.

NCT NCT03969706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03969706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Arm, Open-label, Phase II Study Evaluating the Efficacy and Safety of Abemaciclib in Patients With Recurrent Oligodendroglioma
Lead sponsor
Stephen Bagley, MD, MSCE
Phase
Phase 2
Overall status
Completed
Start date
October 15, 2019
Completion date
February 2, 2026
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oligodendroglioma, adult